Cytokine Storm in IBD: Balancing the Risks of IBD Medical Therapy

Gastroenterology. 2021 Apr;160(5):1878-1880. doi: 10.1053/j.gastro.2020.12.073. Epub 2021 Jan 5.

Authors

Iago Rodríguez-Lago¹, Horacio Alonso-Galán², José Luis Cabriada³

Affiliations

¹ IBD Unit, Gastroenterology Department, Hospital de Galdakao and, Biocruces Health Research Institute, Galdakao, Spain.
² IBD Unit, Gastroenterology Department, Hospital Universitario Donostia, Donostia-San Sebastián, Spain.
³ IBD Unit, Gastroenterology Department, Hospital de Galdakao and, Biocruces Bizkaia Health Research Institute, Galdakao, Spain.

PMID: 33417936
DOI: 10.1053/j.gastro.2020.12.073

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Cytokine Release Syndrome*
Humans
Inflammatory Bowel Diseases* / drug therapy
Inflammatory Bowel Diseases* / epidemiology
Tumor Necrosis Factor-alpha

Substances

Tumor Necrosis Factor-alpha